Concepedia

Use of Prostate Specific Antigen Density Combined with Multiparametric Magnetic Resonance Imaging Improves Triage for Prostate Biopsy

Miroslav Záleský, Jiří Stejskal, Vanda Adamcová, Jan Hrbáček, Ivo Minárik, Adam Pavličko, Jana Votrubová, Marek Babjuk, Roman Zachoval

Urologia Internationalis · 2019 · 12 citations · 15 references

DOI

Abstract

A combination of mpMRI and PSAD might reduce the number of biopsies performed with the cost of missing <4% of CSPC.

References

15

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

Hashim U. Ahmed, Ahmed El‐Shater Bosaily, Louise Brown et al. · The Lancet · 2017 · 3.1K citations · Full text

ESUR prostate MR guidelines 2012

Jelle O. Barentsz, Jonathan Richenberg, R. Clements et al. · European Radiology · 2012 · 2.4K citations · Full text

Pathologic and Clinical Findings to Predict Tumor Extent of Nonpalpable (Stage T1 c) Prostate Cancer

Jonathan I. Epstein · JAMA · 1994 · 1.8K citations

Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate Cancer

Mitchell C. Benson, Ihn Seong Whang, Allan J. Pantuck et al. · The Journal of Urology · 1992 · 767 citations

, , +8

Combination of prostate imaging reporting and data system ( <scp>PI</scp> ‐ <scp>RADS</scp> ) score and prostate‐specific antigen ( <scp>PSA</scp> ) density predicts biopsy outcome in prostate biopsy naïve patients

Satoshi Washino, Tomohisa Okochi, Kimitoshi Saito et al. · British Journal of Urology · 2016 · 303 citations · Full text